HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1

Johan Hartman1, Patrick Müller, James S Foster

  • 1Center for Biotechnology, Department of BioSciences, Karolinska Institutet, Novum, S-141 57 Huddinge Sweden.

Oncogene
|October 7, 2004
PubMed

Insights

All-trans retinoic acid inhibits breast cancer cell growth by downregulating E2F-1 expression via the transcription factor HES-1. This mechanism affects key cell cycle genes, impacting estrogen and heregulin signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The transcription factor HES-1 is crucial for the growth-inhibitory effects of all-trans retinoic acid (ATRA) in breast cancer cells.
  • Estrogen and heregulin-beta1 are known to stimulate breast cancer cell proliferation.

Purpose of the Study:

  • To investigate the role of HES-1 in mediating the effects of ATRA on estrogen- and heregulin-beta1-stimulated breast cancer cell growth.
  • To elucidate the molecular mechanisms by which HES-1 regulates E2F-1 expression and downstream targets.

Main Methods:

  • Utilized T47D breast cancer cells with tetracycline-regulated expression of HES-1 (wild-type and dominant-negative).
  • Assessed cell cycle progression (G1/S transition) and Cdk2 activation.
  • Quantified E2F-1, cyclin E, and NPAT expression following treatment with ATRA, estrogen, or heregulin-beta1.
  • Performed promoter analysis to identify HES-1 binding sites.

Main Results:

  • HES-1 expression inhibited G1/S transition and estrogen-induced Cdk2 activation.
  • ATRA treatment downregulated estrogen- and heregulin-beta1-induced E2F-1 expression, an effect mediated by HES-1.
  • HES-1 directly repressed E2F-1 transcription via a CACGAG-site in the E2F-1 promoter.
  • ATRA inhibited heregulin-beta1-stimulated proliferation via HES-1.
  • Downstream targets of E2F-1, cyclin E and NPAT, were similarly regulated by ATRA and antagonized by dominant-negative HES-1.

Conclusions:

  • HES-1 plays a critical role in inhibiting both estrogen- and heregulin-beta1-stimulated breast cancer cell growth.
  • ATRA induces growth inhibition in these cells through HES-1-mediated downregulation of E2F-1 expression.
  • The HES-1/E2F-1 pathway represents a key mechanism in breast cancer cell proliferation and a potential therapeutic target.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...